Skip to main content
Top
Published in: Digestive Diseases and Sciences 12/2020

Open Access 01-12-2020 | Original Article

Teduglutide Promotes Epithelial Tight Junction Pore Function in Murine Short Bowel Syndrome to Alleviate Intestinal Insufficiency

Authors: Johannes Reiner, Peggy Berlin, Jakob Wobar, Holger Schäffler, Karen Bannert, Manuela Bastian, Brigitte Vollmar, Robert Jaster, Georg Lamprecht, Maria Witte

Published in: Digestive Diseases and Sciences | Issue 12/2020

Login to get access

Abstract

Background

In short bowel syndrome, epithelial surface loss results in impaired nutrient absorption and may lead to intestinal insufficiency or intestinal failure. Nucleotide oligomerization domain 2 (Nod2) dysfunction predisposes to the development of intestinal failure after intestinal resection and is associated with intestinal barrier defects. Epithelial barrier function is crucial for intestinal absorption and for intestinal adaptation in the short bowel situation.

Aims

The aim of the study was to characterize the effects of the GLP-2 analogue Teduglutide in the small intestine in the presence and absence of Nod2 in a mouse model of short bowel syndrome.

Methods

Mice underwent 40% ICR and were thereafter treated with Teduglutide versus vehicle injections. Survival, body weight, stool water, and sodium content and plasma aldosterone concentrations were determined. Intestinal and kidney tissue was examined with light and fluorescence microscopy, Ussing chamber studies and quantitative PCR in wild type and transgenic mice.

Results

Teduglutide reduced intestinal failure incidence in Nod2 k.o. mice. In wt mice, Teduglutide attenuated intestinal insufficiency as indicated by reduced body weight loss and lower plasma aldosterone concentrations, lower stool water content, and lower stool sodium losses. Teduglutide treatment was associated with enhanced epithelial paracellular pore function and enhanced claudin-10 expression in tight junctions in the villus tips, where it colocalized with sodium–glucose cotransporter 1 (SGLT-1), which mediates Na-coupled glucose transport.

Conclusions

In the SBS situation, Teduglutide not only maximizes small intestinal mucosal hypertrophy but also partially restores small intestinal epithelial function through an altered distribution of claudin-10, facilitating sodium recirculation for Na-coupled glucose transport and water absorption.
Literature
1.
go back to reference Pironi L, Arends J, Bozzetti F, et al. ESPEN guidelines on chronic intestinal failure in adults. Clin Nutr. 2016;35:247–307.PubMed Pironi L, Arends J, Bozzetti F, et al. ESPEN guidelines on chronic intestinal failure in adults. Clin Nutr. 2016;35:247–307.PubMed
2.
go back to reference Warner BW. The pathogenesis of resection-associated intestinal adaptation. Cell Mol Gastroenterol Hepatol. 2016;2:429–438.PubMedPubMedCentral Warner BW. The pathogenesis of resection-associated intestinal adaptation. Cell Mol Gastroenterol Hepatol. 2016;2:429–438.PubMedPubMedCentral
3.
go back to reference Seiler KM, Waye SE, Kong W, et al. Single-cell analysis reveals regional reprogramming during adaptation to massive small bowel resection in mice. Cell Mol Gastroenterol Hepatol. 2019;8:407–426.PubMedPubMedCentral Seiler KM, Waye SE, Kong W, et al. Single-cell analysis reveals regional reprogramming during adaptation to massive small bowel resection in mice. Cell Mol Gastroenterol Hepatol. 2019;8:407–426.PubMedPubMedCentral
4.
go back to reference Ladefoged K, Olgaard K. Fluid and electrolyte absorption and renin–angiotensin–aldosterone axis in patients with severe short-bowel syndrome. Scand J Gastroenterol. 1979;14:729–735.PubMed Ladefoged K, Olgaard K. Fluid and electrolyte absorption and renin–angiotensin–aldosterone axis in patients with severe short-bowel syndrome. Scand J Gastroenterol. 1979;14:729–735.PubMed
5.
go back to reference Buchman AL, Scolapio J, Fryer J. AGA technical review on short bowel syndrome and intestinal transplantation. Gastroenterology. 2003;124:1111–1134.PubMed Buchman AL, Scolapio J, Fryer J. AGA technical review on short bowel syndrome and intestinal transplantation. Gastroenterology. 2003;124:1111–1134.PubMed
6.
go back to reference Hampe J, Cuthbert A, Croucher PJ, et al. Association between insertion mutation in NOD2 gene and Crohn’s disease in German and British populations. Lancet. 2001;357:1925–1928.PubMed Hampe J, Cuthbert A, Croucher PJ, et al. Association between insertion mutation in NOD2 gene and Crohn’s disease in German and British populations. Lancet. 2001;357:1925–1928.PubMed
7.
go back to reference Ogura Y, Bonen DK, Inohara N, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn’s disease. Nature. 2001;411:603–606.PubMed Ogura Y, Bonen DK, Inohara N, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn’s disease. Nature. 2001;411:603–606.PubMed
8.
go back to reference Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease. Nature. 2001;411:599–603.PubMed Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease. Nature. 2001;411:599–603.PubMed
9.
go back to reference Schaffler H, Schneider N, Hsieh C-J, et al. NOD2 mutations are associated with the development of intestinal failure in the absence of Crohn’s disease. Clin Nutr. 2013;32:1029–1035.PubMed Schaffler H, Schneider N, Hsieh C-J, et al. NOD2 mutations are associated with the development of intestinal failure in the absence of Crohn’s disease. Clin Nutr. 2013;32:1029–1035.PubMed
10.
go back to reference Ningappa M, Higgs BW, Weeks DE, et al. NOD2 gene polymorphism rs2066844 associates with need for combined liver-intestine transplantation in children with short-gut syndrome. Am J Gastroenterol. 2011;106:157–165.PubMed Ningappa M, Higgs BW, Weeks DE, et al. NOD2 gene polymorphism rs2066844 associates with need for combined liver-intestine transplantation in children with short-gut syndrome. Am J Gastroenterol. 2011;106:157–165.PubMed
11.
go back to reference Berlin P, Reiner J, Witte M, et al. Nod2 deficiency functionally impairs adaptation to short bowel syndrome via alterations of the epithelial barrier function. Am J Physiol Gastrointest Liver Physiol. 2019;317:G727–G738.PubMed Berlin P, Reiner J, Witte M, et al. Nod2 deficiency functionally impairs adaptation to short bowel syndrome via alterations of the epithelial barrier function. Am J Physiol Gastrointest Liver Physiol. 2019;317:G727–G738.PubMed
12.
go back to reference Drucker DJ. The discovery of GLP-2 and development of teduglutide for short bowel syndrome. ACS Pharmacol Transl Sci. 2019;2:134–142.PubMedPubMedCentral Drucker DJ. The discovery of GLP-2 and development of teduglutide for short bowel syndrome. ACS Pharmacol Transl Sci. 2019;2:134–142.PubMedPubMedCentral
13.
go back to reference Jeppesen PB, Sanguinetti EL, Buchman A, et al. Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients. Gut. 2005;54:1224–1231.PubMedPubMedCentral Jeppesen PB, Sanguinetti EL, Buchman A, et al. Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients. Gut. 2005;54:1224–1231.PubMedPubMedCentral
16.
go back to reference Dong CX, Zhao W, Solomon C, et al. The intestinal epithelial insulin-like growth factor-1 receptor links glucagon-like peptide-2 action to gut barrier function. Endocrinology. 2014;155:370–379.PubMed Dong CX, Zhao W, Solomon C, et al. The intestinal epithelial insulin-like growth factor-1 receptor links glucagon-like peptide-2 action to gut barrier function. Endocrinology. 2014;155:370–379.PubMed
17.
go back to reference Amiot A, Messing B, Corcos O, et al. Determinants of home parenteral nutrition dependence and survival of 268 patients with non-malignant short bowel syndrome. Clin Nutr. 2013;32:368–374.PubMed Amiot A, Messing B, Corcos O, et al. Determinants of home parenteral nutrition dependence and survival of 268 patients with non-malignant short bowel syndrome. Clin Nutr. 2013;32:368–374.PubMed
18.
go back to reference Wewer Albrechtsen NJ, Kuhre RE, Torang S, et al. The intestinal distribution pattern of appetite- and glucose regulatory peptides in mice, rats and pigs. BMC Res Notes. 2016;9:60.PubMedPubMedCentral Wewer Albrechtsen NJ, Kuhre RE, Torang S, et al. The intestinal distribution pattern of appetite- and glucose regulatory peptides in mice, rats and pigs. BMC Res Notes. 2016;9:60.PubMedPubMedCentral
19.
go back to reference Jeppesen PB, Gabe SM, Seidner DL, et al. Factors associated with response to teduglutide in patients with short-bowel syndrome and intestinal failure. Gastroenterology. 2018;154:874–885.PubMed Jeppesen PB, Gabe SM, Seidner DL, et al. Factors associated with response to teduglutide in patients with short-bowel syndrome and intestinal failure. Gastroenterology. 2018;154:874–885.PubMed
20.
go back to reference Kobayashi KS, Chamaillard M, Ogura Y, et al. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science. 2005;307:731–734.PubMed Kobayashi KS, Chamaillard M, Ogura Y, et al. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science. 2005;307:731–734.PubMed
21.
go back to reference Komen N, van der Wal H-C, Ditzel M, et al. Colorectal anastomotic leakage: a new experimental model. J Surg Res. 2009;155:7–12.PubMed Komen N, van der Wal H-C, Ditzel M, et al. Colorectal anastomotic leakage: a new experimental model. J Surg Res. 2009;155:7–12.PubMed
22.
go back to reference Rueden CT, Schindelin J, Hiner MC, et al. Image J2: ImageJ for the next generation of scientific image data. BMC Bioinform. 2017;18:529. Rueden CT, Schindelin J, Hiner MC, et al. Image J2: ImageJ for the next generation of scientific image data. BMC Bioinform. 2017;18:529.
23.
go back to reference Reiner J, Hsieh C-J, Straarup C, et al. After intestinal transplantation kidney function is impaired by downregulation of epithelial ion transporters in the ileum. Transplant Proc. 2016;48:499–506.PubMed Reiner J, Hsieh C-J, Straarup C, et al. After intestinal transplantation kidney function is impaired by downregulation of epithelial ion transporters in the ileum. Transplant Proc. 2016;48:499–506.PubMed
24.
go back to reference Bodammer P, Kerkhoff C, Maletzki C, et al. Bovine colostrum increases pore-forming claudin-2 protein expression but paradoxically not ion permeability possibly by a change of the intestinal cytokine milieu. PLoS ONE. 2013;8:e64210.PubMedPubMedCentral Bodammer P, Kerkhoff C, Maletzki C, et al. Bovine colostrum increases pore-forming claudin-2 protein expression but paradoxically not ion permeability possibly by a change of the intestinal cytokine milieu. PLoS ONE. 2013;8:e64210.PubMedPubMedCentral
25.
go back to reference Masilamani S, Kim GH, Mitchell C, et al. Aldosterone-mediated regulation of ENaC alpha, beta, and gamma subunit proteins in rat kidney. J Clin Invest. 1999;104:R19–R23.PubMedPubMedCentral Masilamani S, Kim GH, Mitchell C, et al. Aldosterone-mediated regulation of ENaC alpha, beta, and gamma subunit proteins in rat kidney. J Clin Invest. 1999;104:R19–R23.PubMedPubMedCentral
26.
go back to reference Jeppesen PB, Hartmann B, Thulesen J, et al. Elevated plasma glucagon-like peptide 1 and 2 concentrations in ileum resected short bowel patients with a preserved colon. Gut. 2000;47:370–376.PubMedPubMedCentral Jeppesen PB, Hartmann B, Thulesen J, et al. Elevated plasma glucagon-like peptide 1 and 2 concentrations in ileum resected short bowel patients with a preserved colon. Gut. 2000;47:370–376.PubMedPubMedCentral
27.
go back to reference Drucker DJ, Habener JF, Holst JJ. Discovery, characterization, and clinical development of the glucagon-like peptides. J Clin Invest. 2017;127:4217–4227.PubMedPubMedCentral Drucker DJ, Habener JF, Holst JJ. Discovery, characterization, and clinical development of the glucagon-like peptides. J Clin Invest. 2017;127:4217–4227.PubMedPubMedCentral
28.
go back to reference Odenwald MA, Choi W, Kuo W-T, et al. The scaffolding protein ZO-1 coordinates actomyosin and epithelial apical specializations in vitro and in vivo. J Biol Chem. 2018;293:17317–17335.PubMedPubMedCentral Odenwald MA, Choi W, Kuo W-T, et al. The scaffolding protein ZO-1 coordinates actomyosin and epithelial apical specializations in vitro and in vivo. J Biol Chem. 2018;293:17317–17335.PubMedPubMedCentral
29.
go back to reference Kuo W-T, Shen L, Zuo L, et al. Inflammation-induced occludin downregulation limits epithelial apoptosis by suppressing caspase-3 expression. Gastroenterology. 2019;157:1323–1337.PubMedPubMedCentral Kuo W-T, Shen L, Zuo L, et al. Inflammation-induced occludin downregulation limits epithelial apoptosis by suppressing caspase-3 expression. Gastroenterology. 2019;157:1323–1337.PubMedPubMedCentral
30.
go back to reference Tsai P-Y, Zhang B, He W-Q, et al. IL-22 upregulates epithelial claudin-2 to drive diarrhea and enteric pathogen clearance. Cell Host Microbe. 2017;21:671.e4–681.e4. Tsai P-Y, Zhang B, He W-Q, et al. IL-22 upregulates epithelial claudin-2 to drive diarrhea and enteric pathogen clearance. Cell Host Microbe. 2017;21:671.e4–681.e4.
31.
go back to reference Samanta P, Wang Y, Fuladi S, et al. Molecular determination of claudin-15 organization and channel selectivity. J Gen Physiol. 2018;150:949–968.PubMedPubMedCentral Samanta P, Wang Y, Fuladi S, et al. Molecular determination of claudin-15 organization and channel selectivity. J Gen Physiol. 2018;150:949–968.PubMedPubMedCentral
32.
33.
go back to reference Raleigh DR, Boe DM, Yu D, et al. Occludin S408 phosphorylation regulates tight junction protein interactions and barrier function. J Cell Biol. 2011;193:565–582.PubMedPubMedCentral Raleigh DR, Boe DM, Yu D, et al. Occludin S408 phosphorylation regulates tight junction protein interactions and barrier function. J Cell Biol. 2011;193:565–582.PubMedPubMedCentral
34.
go back to reference Wada M, Tamura A, Takahashi N, et al. Loss of claudins 2 and 15 from mice causes defects in paracellular Na+ flow and nutrient transport in gut and leads to death from malnutrition. Gastroenterology. 2013;144:369–380.PubMed Wada M, Tamura A, Takahashi N, et al. Loss of claudins 2 and 15 from mice causes defects in paracellular Na+ flow and nutrient transport in gut and leads to death from malnutrition. Gastroenterology. 2013;144:369–380.PubMed
36.
go back to reference Naimi RM, Hvistendahl M, Enevoldsen LH, et al. Glepaglutide, a novel long-acting glucagon-like peptide-2 analogue, for patients with short bowel syndrome: a randomised phase 2 trial. Lancet Gastroenterol Hepatol. 2019;4:354–363.PubMed Naimi RM, Hvistendahl M, Enevoldsen LH, et al. Glepaglutide, a novel long-acting glucagon-like peptide-2 analogue, for patients with short bowel syndrome: a randomised phase 2 trial. Lancet Gastroenterol Hepatol. 2019;4:354–363.PubMed
37.
go back to reference Jeppesen PB, Gilroy R, Pertkiewicz M, et al. Randomised placebo-controlled trial of teduglutide in reducing parenteral nutrition and/or intravenous fluid requirements in patients with short bowel syndrome. Gut. 2011;60:902–914.PubMedPubMedCentral Jeppesen PB, Gilroy R, Pertkiewicz M, et al. Randomised placebo-controlled trial of teduglutide in reducing parenteral nutrition and/or intravenous fluid requirements in patients with short bowel syndrome. Gut. 2011;60:902–914.PubMedPubMedCentral
38.
go back to reference Seidner DL, Fujioka K, Boullata JI, et al. Reduction of parenteral nutrition and hydration support and safety with long-term teduglutide treatment in patients with short bowel syndrome-associated intestinal failure: STEPS-3 study. Nutr Clin Pract. 2018;33:520–527.PubMed Seidner DL, Fujioka K, Boullata JI, et al. Reduction of parenteral nutrition and hydration support and safety with long-term teduglutide treatment in patients with short bowel syndrome-associated intestinal failure: STEPS-3 study. Nutr Clin Pract. 2018;33:520–527.PubMed
40.
go back to reference Pevny S, Maasberg S, Rieger A, et al. Experience with teduglutide treatment for short bowel syndrome in clinical practice. Clin Nutr. 2019;38:1745–1755.PubMed Pevny S, Maasberg S, Rieger A, et al. Experience with teduglutide treatment for short bowel syndrome in clinical practice. Clin Nutr. 2019;38:1745–1755.PubMed
41.
go back to reference Drucker DJ, Erlich P, Asa SL, et al. Induction of intestinal epithelial proliferation by glucagon-like peptide 2. Proc Natl Acad Sci USA. 1996;93:7911–7916.PubMed Drucker DJ, Erlich P, Asa SL, et al. Induction of intestinal epithelial proliferation by glucagon-like peptide 2. Proc Natl Acad Sci USA. 1996;93:7911–7916.PubMed
42.
go back to reference Seidner DL, Joly F, Youssef NN. Effect of teduglutide, a glucagon-like peptide 2 analog, on citrulline levels in patients with short bowel syndrome in two phase III randomized trials. Clin Transl Gastroenterol. 2015;6:e93.PubMedPubMedCentral Seidner DL, Joly F, Youssef NN. Effect of teduglutide, a glucagon-like peptide 2 analog, on citrulline levels in patients with short bowel syndrome in two phase III randomized trials. Clin Transl Gastroenterol. 2015;6:e93.PubMedPubMedCentral
43.
go back to reference Lai SW, de Heuvel E, Wallace LE, et al. Effects of exogenous glucagon-like peptide-2 and distal bowel resection on intestinal and systemic adaptive responses in rats. PLoS ONE. 2017;12:e0181453.PubMedPubMedCentral Lai SW, de Heuvel E, Wallace LE, et al. Effects of exogenous glucagon-like peptide-2 and distal bowel resection on intestinal and systemic adaptive responses in rats. PLoS ONE. 2017;12:e0181453.PubMedPubMedCentral
44.
go back to reference Bertoni S, Gabella G. Hypertrophy of mucosa and serosa in the obstructed intestine of rats. J Anat. 2001;199:725–734.PubMedPubMedCentral Bertoni S, Gabella G. Hypertrophy of mucosa and serosa in the obstructed intestine of rats. J Anat. 2001;199:725–734.PubMedPubMedCentral
45.
go back to reference Schäffler H, Demircioglu DD, Kühner D, et al. NOD2 stimulation by Staphylococcus aureus-derived peptidoglycan is boosted by Toll-like receptor 2 costimulation with lipoproteins in dendritic cells. Infect Immun. 2014;82:4681–4688.PubMedPubMedCentral Schäffler H, Demircioglu DD, Kühner D, et al. NOD2 stimulation by Staphylococcus aureus-derived peptidoglycan is boosted by Toll-like receptor 2 costimulation with lipoproteins in dendritic cells. Infect Immun. 2014;82:4681–4688.PubMedPubMedCentral
47.
go back to reference Rossier BC, Baker ME, Studer RA. Epithelial sodium transport and its control by aldosterone: the story of our internal environment revisited. Physiol Rev. 2015;95:297–340.PubMed Rossier BC, Baker ME, Studer RA. Epithelial sodium transport and its control by aldosterone: the story of our internal environment revisited. Physiol Rev. 2015;95:297–340.PubMed
48.
go back to reference Dekaney CM, Fong JJ, Rigby RJ, et al. Expansion of intestinal stem cells associated with long-term adaptation following ileocecal resection in mice. Am J Physiol Gastrointest Liver Physiol. 2007;293:G1013–G1022.PubMed Dekaney CM, Fong JJ, Rigby RJ, et al. Expansion of intestinal stem cells associated with long-term adaptation following ileocecal resection in mice. Am J Physiol Gastrointest Liver Physiol. 2007;293:G1013–G1022.PubMed
50.
go back to reference Ives GC, Demehri FR, Sanchez R, et al. Small bowel diameter in short bowel syndrome as a predictive factor for achieving enteral autonomy. J Pediatr. 2016;178:275.e1–277.e1. Ives GC, Demehri FR, Sanchez R, et al. Small bowel diameter in short bowel syndrome as a predictive factor for achieving enteral autonomy. J Pediatr. 2016;178:275.e1–277.e1.
51.
go back to reference Shen L, Weber CR, Raleigh DR, et al. Tight junction pore and leak pathways: a dynamic duo. Annu Rev Physiol. 2011;73:283–309.PubMedPubMedCentral Shen L, Weber CR, Raleigh DR, et al. Tight junction pore and leak pathways: a dynamic duo. Annu Rev Physiol. 2011;73:283–309.PubMedPubMedCentral
52.
go back to reference Furuse M, Furuse K, Sasaki H, et al. Conversion of zonulae occludentes from tight to leaky strand type by introducing claudin-2 into Madin-Darby canine kidney I cells. J Cell Biol. 2001;153:263–272.PubMedPubMedCentral Furuse M, Furuse K, Sasaki H, et al. Conversion of zonulae occludentes from tight to leaky strand type by introducing claudin-2 into Madin-Darby canine kidney I cells. J Cell Biol. 2001;153:263–272.PubMedPubMedCentral
53.
go back to reference Tamura A, Kitano Y, Hata M, et al. Megaintestine in claudin-15-deficient mice. Gastroenterology. 2008;134:523–534.PubMed Tamura A, Kitano Y, Hata M, et al. Megaintestine in claudin-15-deficient mice. Gastroenterology. 2008;134:523–534.PubMed
54.
go back to reference Bines JE, Taylor RG, Justice F, et al. Influence of diet complexity on intestinal adaptation following massive small bowel resection in a preclinical model. J Gastroenterol Hepatol. 2002;17:1170–1179.PubMed Bines JE, Taylor RG, Justice F, et al. Influence of diet complexity on intestinal adaptation following massive small bowel resection in a preclinical model. J Gastroenterol Hepatol. 2002;17:1170–1179.PubMed
55.
go back to reference Schulzke JD, Fromm M, Bentzel CJ, et al. Ion transport in the experimental short bowel syndrome of the rat. Gastroenterology. 1992;102:497–504.PubMed Schulzke JD, Fromm M, Bentzel CJ, et al. Ion transport in the experimental short bowel syndrome of the rat. Gastroenterology. 1992;102:497–504.PubMed
56.
go back to reference Weber CR, Liang GH, Wang Y, et al. Claudin-2-dependent paracellular channels are dynamically gated. Elife. 2015;4:e09906.PubMedPubMedCentral Weber CR, Liang GH, Wang Y, et al. Claudin-2-dependent paracellular channels are dynamically gated. Elife. 2015;4:e09906.PubMedPubMedCentral
57.
go back to reference Turner JR, Buschmann MM, Romero-Calvo I, et al. The role of molecular remodeling in differential regulation of tight junction permeability. Semin Cell Dev Biol. 2014;36:204–212.PubMed Turner JR, Buschmann MM, Romero-Calvo I, et al. The role of molecular remodeling in differential regulation of tight junction permeability. Semin Cell Dev Biol. 2014;36:204–212.PubMed
58.
go back to reference Tamura A, Hayashi H, Imasato M, et al. Loss of claudin-15, but not claudin-2, causes Na+ deficiency and glucose malabsorption in mouse small intestine. Gastroenterology. 2011;140:913–923.PubMed Tamura A, Hayashi H, Imasato M, et al. Loss of claudin-15, but not claudin-2, causes Na+ deficiency and glucose malabsorption in mouse small intestine. Gastroenterology. 2011;140:913–923.PubMed
59.
go back to reference Gunzel D, Stuiver M, Kausalya PJ, et al. Claudin-10 exists in six alternatively spliced isoforms that exhibit distinct localization and function. J Cell Sci. 2009;122:1507–1517.PubMed Gunzel D, Stuiver M, Kausalya PJ, et al. Claudin-10 exists in six alternatively spliced isoforms that exhibit distinct localization and function. J Cell Sci. 2009;122:1507–1517.PubMed
60.
61.
go back to reference van Itallie CM, Tietgens AJ, Anderson JM. Visualizing the dynamic coupling of claudin strands to the actin cytoskeleton through ZO-1. Mol Biol Cell. 2017;28:524–534.PubMedPubMedCentral van Itallie CM, Tietgens AJ, Anderson JM. Visualizing the dynamic coupling of claudin strands to the actin cytoskeleton through ZO-1. Mol Biol Cell. 2017;28:524–534.PubMedPubMedCentral
62.
go back to reference Holmes JL, van Itallie CM, Rasmussen JE, et al. Claudin profiling in the mouse during postnatal intestinal development and along the gastrointestinal tract reveals complex expression patterns. Gene Expr Patterns. 2006;6:581–588.PubMed Holmes JL, van Itallie CM, Rasmussen JE, et al. Claudin profiling in the mouse during postnatal intestinal development and along the gastrointestinal tract reveals complex expression patterns. Gene Expr Patterns. 2006;6:581–588.PubMed
63.
go back to reference Madunic IV, Breljak D, Karaica D, et al. Expression profiling and immunolocalization of Na(+)-d-glucose-cotransporter 1 in mice employing knockout mice as specificity control indicate novel locations and differences between mice and rats. Pflugers Arch. 2017;469:1545–1565.PubMedPubMedCentral Madunic IV, Breljak D, Karaica D, et al. Expression profiling and immunolocalization of Na(+)-d-glucose-cotransporter 1 in mice employing knockout mice as specificity control indicate novel locations and differences between mice and rats. Pflugers Arch. 2017;469:1545–1565.PubMedPubMedCentral
Metadata
Title
Teduglutide Promotes Epithelial Tight Junction Pore Function in Murine Short Bowel Syndrome to Alleviate Intestinal Insufficiency
Authors
Johannes Reiner
Peggy Berlin
Jakob Wobar
Holger Schäffler
Karen Bannert
Manuela Bastian
Brigitte Vollmar
Robert Jaster
Georg Lamprecht
Maria Witte
Publication date
01-12-2020
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 12/2020
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-020-06140-6

Other articles of this Issue 12/2020

Digestive Diseases and Sciences 12/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.